TAGLN and aneurysm: In contrast, 4-OHT administration from E10.5 to E11.5, mimicking the later recombination by Tagln-Cre, did not lead to aneurysm formation by E13.5 but induced a milder dilation of the carotid arteries (Fig. 7e–g).